# Investigation of vitamin D deficiency in girls with growth and development variations—a single center study

**Authors:** Panwang Huang, Beilei Zeng, Feng Ren, Yuan Zhou, Ye Li, Yinyin Huang, Xingyu Liu, Jiaxiu Zhou, Yaping Ma

PMC · DOI: 10.3389/fped.2025.1518548 · Frontiers in Pediatrics · 2025-01-27

## TL;DR

This study examines vitamin D deficiency in girls with growth and developmental variations and finds that early puberty, menarche, and obesity are associated with lower vitamin D levels.

## Contribution

The study provides new insights into vitamin D deficiency in specific pediatric populations and its relation to growth and development.

## Key findings

- Girls with early puberty, menarche, and obesity had significantly lower vitamin D levels compared to controls.
- Vitamin D deficiency rates were highest in the menarche group (73.91%) and lowest in the short stature group (30.95%).
- There was no significant difference in vitamin D levels before and after the COVID-19 epidemic.

## Abstract

To understand the status of vitamin D deficiency in girls with growth and developmental variations, as well as the impact of COVID−19 on their vitamin D levels, and to provide reference for the prevention and treatment of vitamin D deficiency in children.

A retrospective analysis was conducted on 1,345 instances of girls with growth and developmental variations who visited our pediatric endocrinology department and completed vitamin D detection. A total of 279 girls with complete data were included in this study. Among them, 246 girls were classified into four groups based on different growth and developmental variations: early puberty group, menarche group, obesity group, short stature group, and 33 healthy girls served as the control group. Besides, the girls were divided into pre-epidemic and post-epidemic groups by the occurrence of the COVID-19 epidemic. Vitamin D were measured in all girls. The 25(OH)D <20 ng/ml was used as the standard for vitamin D deficiency.

The levels of vitamin D in the early puberty group, menarche group, obesity group, short stature group, and control group were as follows: 20.23 ± 5.90 ng/ml, 17.85 ± 5.69 ng/ml, 21.31 ± 8.99 ng/ml, 27.90 ± 12.27 ng/ml, and 29.42 ± 12.65 ng/ml, respectively. The levels of vitamin D in the early puberty group, menarche group, and obesity group were significantly lower than those in the control group (P < 0.05). The individual vitamin D deficiency rates in the aforementioned groups were 52.07%, 73.91%, 59.46%, 30.95%, and 30.30%, respectively. The vitamin D levels in the pre-epidemic and post-epidemic groups were 20.48 ± 6.22 ng/ml and 22.50 ± 9.74 ng/ml, respectively (P > 0.05).

Girls with early puberty, menarche, and obesity have a certain deficiency of vitamin D levels, and appropriate vitamin D treatment should be provided clinically. Girls with short stature and healthy girls also have certain levels of vitamin D deficiency, and awareness of prevention should be strengthened.

## Full-text entities

- **Diseases:** short stature (MESH:D006130), vitamin D deficiency (MESH:D014808), and developmental variations (OMIM:610141), obesity (MESH:D009765), COVID-19 (MESH:D000086382)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11808006/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11808006/full.md

## References

40 references — full list in the complete paper: https://tomesphere.com/paper/PMC11808006/full.md

---
Source: https://tomesphere.com/paper/PMC11808006